Business Standard

Sunday, January 19, 2025 | 07:41 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Centre bans 328 fixed-dose combination drugs over safety grounds

The ban follows the recommendation of the drug technical advisory board (DTAB)

Approval for generics drug up but US business shrinks for home firms
Premium

Aneesh Phadnis Mumbai
The health ministry on Wednesday notified a ban on 328 fixed-dose combination (FDC) drugs on safety grounds.

The ban follows the recommendation of the drug technical advisory board (DTAB). The manufacture and sale of six FDCs will be restricted. These include anti-diabetic drugs, antibiotics, and analgesics. 

The DTAB had in June originally recommended against 349 drugs, but 15 drugs, approved prior to 1988, have been kept outside the purview of the ban. This follows a Supreme Court (SC) order last week, which restrained the government from banning those 15 drugs. The 15 drugs, which include cough and cold medicines Phensedyl

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in